Mv Capital Management, Inc. Bristol Myers Squibb CO Transaction History

Mv Capital Management, Inc.

$931 Million
Q2 2025

A detailed history of Mv Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mv Capital Management, Inc. holds 1,021 shares of BMY stock, worth $47,037. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,021

Previous 2,643 61.37%

Holding current value

$47,037

Previous $161,000 70.81%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$44.12 - $59.6 $71,562 - $96,671	-1,622 Reduced 61.37%	1,021 $47,000
Q1 2025 Apr 15, 2025	SELL	$53.9 - $63.11 $27,596 - $32,312	-512 Reduced 16.23%	2,643 $161,000
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $23,675 - $27,332	456 Added 16.9%	3,155 $178,000
Q3 2024 Nov 04, 2024	SELL	$39.66 - $51.75 $9,161 - $11,954	-231 Reduced 7.88%	2,699 $139,000
Q2 2024 Aug 01, 2024	BUY	$40.25 - $52.99 $37,875 - $49,863	941 Added 47.31%	2,930 $121,000
Q1 2024 Apr 18, 2024	SELL	$47.98 - $54.4 $20,391 - $23,120	-425 Reduced 17.61%	1,989 $107,000
Q4 2023 Jan 29, 2024	BUY	$48.48 - $57.85 $3,732 - $4,454	77 Added 3.29%	2,414 $123,000
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $10,651 - $11,910	184 Added 8.55%	2,337 $135,000
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $12,168 - $13,511	191 Added 9.73%	2,153 $137,000
Q1 2023 Apr 26, 2023	BUY	$65.71 - $74.53 $3,351 - $3,801	51 Added 2.67%	1,962 $135,000
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $8,217 - $9,730	120 Added 6.7%	1,911 $0
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $43 - $25,818	336 Added 23.09%	1,791 $127,000
Q2 2022 Jul 19, 2022	BUY	$72.62 - $79.98 $4,647 - $5,118	64 Added 4.6%	1,455 $112,000
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $8,299 - $9,952	135 Added 10.75%	1,391 $102,000
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $2,091 - $2,438	39 Added 3.2%	1,256 $78,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $5,680 - $6,653	96 Added 8.56%	1,217 $72,000
Q2 2021 Aug 03, 2021	BUY	$61.91 - $67.42 $43,275 - $47,126	699 Added 165.64%	1,121 $75,000
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $71,445 - $80,354	-1,204 Reduced 74.05%	422 $27,000
Q1 2020 Apr 28, 2020	BUY	$46.4 - $67.43 $1,763 - $2,562	38 Added 2.39%	1,626 $91,000
Q4 2019 Feb 05, 2020	SELL	$49.21 - $64.19 $2,804 - $3,658	-57 Reduced 3.47%	1,588 $102,000
Q3 2019 Nov 21, 2019	BUY	$42.77 - $50.71 $58,979 - $69,929	1,379 Added 518.42%	1,645 $83,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $2,887 - $3,443	-64 Reduced 19.39%	266 $13,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $36,570 - $47,422	-750 Reduced 69.44%	330 $17,000
Q1 2018 May 09, 2018	BUY	$59.92 - $68.98 $44,940 - $51,735	750 Added 227.27%	1,080 $68,000
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $18,225 - $21,034	330	330 $21,000

Others Institutions Holding BMY

# of Institutions

2,668

Shares Held

1.64B

Call Options Held

22.5M

Put Options Held

25.3M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $98B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.

Account

Mv Capital Management, Inc. Bristol Myers Squibb CO Transaction History